Milestone Pharmaceuticals Inc (MIST) saw an uptrend of 1030381% in the recent trading with $2120000.0 being its most recent. The current price level -36.00% lower than the highest price of $2.75 marked by the stock while trading over the past 52-weeks, whereas it is 181.42% higher than the lowest price of $0.63 the company dropped to over past 52-weeks. The latest news story on MIST appeared in (GlobeNewswire) under the title “Milestone Pharmaceuticals Submits Response to the FDA’s CRL for CARDAMYST (etripamil) Nasal Spray for PSVT Following Type A Meeting” on Jun-16-25.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Moderate Buy by 3 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 2.00 for the stock.
Milestone Pharmaceuticals Inc Earnings – What Happened With MIST
Coming around sales and income figures on MIST Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
Milestone Pharmaceuticals Inc – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 53.46 million. MIST does have institutional investors; and they hold 22.24% of the stock.
As on 2024-06-30, BLACKROCK INC. was the top most holder in Milestone Pharmaceuticals Inc (NASDAQ:MIST) with an ownership of 4.97 million shares of the company or 7.5135 of the stake worth $6.56 million. The filing also reveals RTW INVESTMENTS, LP as the second largest holder in the company with a control over 4.9211 of the outstanding shares. Its stake is worth $4.3 million for having 3.26 million shares in hand.
MILLENNIUM MANAGEMENT LLC also came holding a key position in the company during the recent quarter and it now holds 4.1561 of the outstanding shares. With this there are now 49.0 institutions which have possession in MIST’s shares.
Key Metrics forMIST
Technical Analysis of Milestone Pharmaceuticals Inc (NASDAQ:MIST) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Milestone Pharmaceuticals Inc (MIST), we notice that the stock’s 20-day average volume is at 688,020 shares and 100% of short term indicators are suggesting the stock as Buy. Medium term indicators at an average of 50% are spotting the stock at Sell with its 50-day average volume of 1,088,452 shares. And to end, MIST’s 100-day average volume is 1,899,395 shares with 50% of the long-term indicators pointing towards Buy for the stock.
